MKI67 and adrenal cortex carcinoma: All three PDX models were validated as ACC tumors based on IHC expression of the common NE marker synaptophysin, the adrenal-specific marker SF1, and the cell proliferation marker Ki67 (Supplementary Fig. 6B–D).